scispace - formally typeset
C

Costas T. Lambrew

Researcher at Maine Medical Center

Publications -  49
Citations -  7672

Costas T. Lambrew is an academic researcher from Maine Medical Center. The author has contributed to research in topics: Myocardial infarction & Thrombolysis. The author has an hindex of 27, co-authored 49 publications receiving 7452 citations. Previous affiliations of Costas T. Lambrew include Harvard University & University of Washington.

Papers
More filters
Journal ArticleDOI

Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.

TL;DR: The relationship in this study between increased mortality and delay in door-to-balloon time longer than 2 hours (present in nearly 50% of this cohort) suggests that physicians and health care systems should work to minimize door- to- balloon times and that door- To-Balloon time should be considered when choosing a reperfusion strategy.
Journal ArticleDOI

A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group

Gerald T. O'Connor, +145 more
- 20 Mar 1996 - 
TL;DR: It is concluded that a multi-institutional, regional model for the continuous improvement of surgical care is feasible and effective and may have applications in other settings.
Journal ArticleDOI

Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 Patients

TL;DR: The finding of a murmur before the age of 1 year in 9 of the 64 patients, and the reports of IHSS in a stillborn baby and in several infants, as well as the association of IhSS with congenital cardiac malformations, all support the concept that the disease may, at least in some instances, be congenital.
Journal ArticleDOI

Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain.

TL;DR: It is suggested that patients without chest pain on presentation represent a large segment of the myocardial infarction population and are at increased risk for delays in seeking medical attention, less aggressive treatments, and in-hospital mortality.
Journal ArticleDOI

Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: The National Registry of Myocardial Infarction 1, 2 and 3

TL;DR: The NRMI data demonstrate that the recommendations of recent clinical trials and published guidelines are being implemented, resulting in more rapid administration of intravenous thrombolytic therapy, increasing use of primary angioplasty and more frequent use of adjunctive therapies known to reduce mortality, and may be contributing to the higher prevalence of non-Q wave infarctions, shorter hospital stays and lower hospital mortality.